Serial Number
99549992
Owner
Concorde Health Inc.Attorney
Michael S. PalmiscianoFiling Date
Dec 16, 2025
CONCORDE HEALTH Trademark
Serial Number: 99549992
Trademark Classes
Class 9 - Computers & Electronics
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
Legal Representation
Correspondence Address
Michael S. Palmisciano Sullivan & Worcester LLP
1251 Avenue of the Americas
New York, NY 10020
United States
Trademark Details
Filing Date
December 16, 2025
Registration Date
Not Registered
Published for Opposition
August 11, 2026
Goods & Services
Business consulting services in the field of employee wellness and health optimization; providing business data analytics and reporting services related to employee health outcomes, medication adherence, and return on investment for employer-sponsored wellness programs; compiling and analyzing workforce health data for business purposes to improve employee productivity and business performance
Downloadable mobile applications for use in behavior modification and chronic disease prevention; downloadable mobile applications featuring software for tracking GLP-1 medication usage, monitoring and analyzing biometric and behavioral health metrics, delivering personalized wellness recommendations, facilitating coaching sessions, providing access to educational content and digital libraries in the field of health and wellness, generating customized health interventions based on user health data, and supporting sustained behavior and lifestyle change through artificial intelligence-driven habit formation and behavioral science-based engagement
Wellness and health-related consulting services in the fields of chronic disease prevention and behavior modification; providing personalized health assessments, GLP-1 medication optimization guidance, and lifestyle intervention programs delivered via digital platforms and virtual coaching sessions